What is the recommended dosing regimen of metoprolol tartrate for hypertension, chronic stable angina, atrial‑fibrillation rate control, and acute myocardial infarction, including dose adjustments for elderly patients, severe hepatic impairment, and renal dysfunction?

Metoprolol Tartrate Dosing

For acute myocardial infarction, initiate metoprolol tartrate with 5 mg IV every 5 minutes for up to 3 doses (15 mg total), followed by 25-50 mg orally every 6 hours starting 15 minutes after the last IV dose, then transition to 100 mg twice daily maintenance. 1, 2

Acute Myocardial Infarction (STEMI/NSTEMI)

Initial IV Dosing (First 24 Hours)

• 5 mg IV bolus over 1-2 minutes
• Repeat every 5 minutes up to 3 doses (15 mg total) 1, 3, 4
• Monitor blood pressure, heart rate, and ECG continuously during IV administration 1, 2

Transition to Oral Therapy

• If patient tolerates full 15 mg IV dose:

  • Start 25-50 mg orally every 6 hours beginning 15 minutes after last IV dose 1, 3, 4
  • Continue for 48 hours
  • Then transition to 100 mg twice daily maintenance 1, 3, 4

• If patient does NOT tolerate full IV dose:

  • Start 25 mg orally every 6 hours (or 50 mg depending on degree of intolerance) 1
  • Begin 15 minutes after last IV dose or when clinically stable

Alternative Oral-Only Approach

Oral beta blockers should be initiated within the first 24 hours in hemodynamically stable patients without contraindications 1, 5. This approach is now preferred given COMMIT trial data showing increased cardiogenic shock risk with aggressive early IV dosing 3, 6, 5.

• Start 25-50 mg orally in lower doses if IV initiation is not indicated 3, 4
• Titrate gradually based on heart rate and blood pressure tolerance

Target Heart Rate

• 50-60 beats per minute at rest unless limiting side effects occur 3, 4

Critical Contraindications to Avoid

Do NOT give beta blockers if any of the following are present: 1, 3, 6, 5

• Signs of heart failure (rales, S3 gallop)
• Evidence of low output state (oliguria)
• Increased risk for cardiogenic shock (age >70 years, systolic BP <120 mmHg, heart rate >110 or <60 bpm, Killip class II-III)
• PR interval >0.24 seconds
• Second- or third-degree heart block without pacemaker
• Active asthma or reactive airways disease
• Systolic BP <90 mmHg

The COMMIT trial demonstrated that early aggressive IV beta blockade increases cardiogenic shock risk by 30%, particularly in the first 24 hours, despite reducing reinfarction and ventricular fibrillation 3, 6, 5. The excess shock occurred primarily in hemodynamically unstable patients.

Hypertension

Standard Dosing

• Initial: 25-100 mg twice daily 7
• Maintenance: 100-450 mg daily in divided doses (typically 100 mg twice daily) 8
• Titrate based on blood pressure response

Elderly Patients

• Start at low doses (e.g., 25 mg twice daily) 2
• Titrate cautiously due to greater frequency of decreased hepatic, renal, or cardiac function 2
• Studies show metoprolol 100 mg once daily is effective and well-tolerated in elderly hypertensive patients aged 50-75 years 9

Chronic Stable Angina

• 50-200 mg twice daily 3
• Individualize dosing based on symptom control and heart rate response
• Studies suggest once-daily formulations may improve compliance over twice-daily dosing 10

Atrial Fibrillation Rate Control

Acute Setting (IV)

• 2.5-5 mg IV bolus over 2 minutes 7, 11, 12
• May repeat up to 3 doses 7, 11
• Onset of action: 5 minutes 7

Chronic Maintenance (Oral)

• Metoprolol tartrate: 25-100 mg twice daily 7, 12
• Metoprolol succinate: 50-400 mg daily 12
• Titrate to achieve adequate rate control (typically <110 bpm at rest, <80 bpm with activity)

Note: Some evidence suggests weight-based dosing strategies may be more effective, though data is limited 13. Traditional flat-dose metoprolol may be less effective than weight-based diltiazem for acute AF with RVR.

Special Populations

Hepatic Impairment

• Initiate at LOW doses with cautious gradual titration 2
• Metoprolol blood levels increase substantially in hepatic impairment due to reduced first-pass metabolism 2, 14
• Clearance decreases significantly (36.6 L/h vs 48 L/h in healthy subjects) 14

Renal Dysfunction

• No dose adjustment required 2
• Metoprolol is primarily hepatically metabolized 2, 14

Elderly Patients (>65 years)

• Start with low initial doses 2
• Use cautious gradual titration
• Monitor closely for bradycardia, hypotension, and heart failure 2

Key Clinical Pearls

• Metoprolol tartrate has a half-life of 3-4 hours, requiring twice-daily dosing for sustained effect 12
• Metoprolol succinate (extended-release) has a half-life of 3-7 hours and can be dosed once daily 12
• Therapeutic plasma concentrations around 200 nmol/L provide significant beta-blockade 15
• Drug interactions: Metoprolol is a CYP2D6 substrate; co-administration with CYP2D6 inhibitors significantly increases plasma levels 14
• Avoid abrupt discontinuation in patients with coronary artery disease to prevent rebound ischemia